Study on TCM syndrome differentiation of primary liver cancer based on the analysis of latent structural model

12Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Primary liver cancer (PLC) is one of the most common malignant tumors because of its high incidence and high mortality. Traditional Chinese medicine (TCM) plays an active role in the treatment of PLC. As the most important part in the TCM system, syndrome differentiation based on the clinical manifestations from traditional four diagnostic methods has met great challenges and questions with the lack of statistical validation support. In this study, we provided evidences for TCM syndrome differentiation of PLC using the method of analysis of latent structural model from clinic data, thus providing basis for establishing TCM syndrome criteria. And also we obtain the common syndromes of PLC as well as their typical clinical manifestations, respectively.

Cite

CITATION STYLE

APA

Gu, Z., Qi, X., Zhai, X., Lang, Q., Lu, J., Ma, C., … Yue, X. (2015). Study on TCM syndrome differentiation of primary liver cancer based on the analysis of latent structural model. Evidence-Based Complementary and Alternative Medicine, 2015. https://doi.org/10.1155/2015/761565

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free